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During an epidemiological investigation of asthma in an occupational setting, 1126 subjects completed 
a modified Medical Research Council respiratory questionnaire, then underwent airway responsiveness 
measurements as PD,,FEV, to methacholine. Previous experience of bronchoconstriction was assessed in the 
481 subjects with measurable airway responsiveness (PD,,FEV,c6400 g) by asking ‘have you ever felt like this 
before’ at the end of their methacholine challenge tests, i.e. when the subjects were bronchoconstricted by 
FEV, decrements of at least 20%. The responses to this question bore no relationship to the previously 
administered questionnaire responses about wheezing, chest tightness, coughing, or breathlessness. However, 
there was an inverse relationship with PD,,FEV, measurements (P<O.OOl), the positive response rate to 
the question falling from 92% among those with PD,,FEV, <5Opg to 27% among those with PD,,FEV, in the 
highest measurable range (320&64OOpg). This suggests that airway responsiveness measurements are a more 
reliable guide to subjects’ previous experience of substantial bronchoconstriction (i.e. asthma) than are the 
responses to respiratory questionnaires. 
Introduction 
Many aspects of the epidemiology of asthma 
remain to be defined. There appears to be quite large 
geographical differences in its prevalence, and there is 
strong suspicion that its overall prevalence is increas- 
ing (1). However, both of these factors could be due 
to differences or changes in diagnostic fashion and 
further developments in the field of asthma epidemi- 
ology will require carefully standardized diagnostic 
criteria. 
Respiratory questionnaires have been widely used 
to identify asthmatic subjects in epidemiological 
studies (2). However, words such as ‘wheezing’, ‘chest 
tightness’ and ‘breathlessness’ lack specificity and the 
responses to questionnaires can be influenced by their 
design, the respondent’s level of comprehension, self- 
image, and vested interest, as well as the presence of 
respiratory disease. In contrast to the widely accepted 
Medical Research Council (MRC) questionnaire 
for chronic bronchitis (3), there is as yet no fully 
validated questionnaire for asthma. 
More recently, measurements of airway respon- 
siveness to histamine or methacholine have been used 
as surrogates for asthma in epidemiological studies 
(45). They are objective and repeatable, and they 
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correlate with other measures of asthmatic activity 
such as use of medication and diurnal variation of 
peak expiratory flow rate (4). However, airway 
responsiveness measurements are not specific, and 
are increased in other obstructive lung diseases. Fur- 
thermore, as they are unimodally distributed in the 
population at large, the choice of abnormal values is 
somewhat arbitrary. 
Even considering these problems, it is surprising 
how poorly questionnaires and airway responsiveness 
measurements relate to each other in epidemiological 
studies of asthma. Symptoms such as ‘wheeze’ have 
been recorded in 1162% of hyper-responsive sub- 
jects and in 3-27% of subjects with ‘normal’ levels of 
airway responsiveness (6-l 1). This begs the question 
of which is the better measure of asthma in an 
epidemiological setting - a question which is difficult 
to answer in the absence of a diagnostic ‘gold 
standard’. 
The symptoms of asthma are largely due to the 
sensations associated with bronchoconstriction. We 
have therefore postulated that subjects’ familiarity 
with these sensations ought to be of some assistance 
in determining their previous experience of broncho- 
constriction and in establishing a diagnosis of 
asthma. To investigate this, we have enquired 
about the recognition of bronchoconstriction pro- 
voked during methacholine challenge tests in an 
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epidemiological study, and compared the responses 
with the results of questionnaires and measurements 
of airway responsiveness. 
Materials and Methods 
The study was conducted in a shipyard in the 
North of England during the summer months of 1989 
and 1990. All apprentice welders and painters who 
had entered the shipyard between 1980 and 1987 
were studied, together with similar numbers of other 
shopfloor and office workers, and school leavers 
about to start work in 1989 and 1990. A total of 1126 
subjects were studied. Their mean age was 21 years 
and 50 were female. All 1126 subjects completed a 
questionnaire and then underwent spirometric and 
airway responsiveness measurements, together with a 
number of other investigations. Bronchodilators were 
withheld for at least 12 h before the study. All 
subjects gave written informed consent and the study 
was approved by the local Ethics Committee. 
The questionnaire was developed from the MRC 
Respiratory Symptom Questionnaire, but was 
modified to include questions designed to diagnose 
asthma and quantify its severity. It was administered 
in a standardized manner by a doctor, a nurse, or 
a trained technician. Information about previous 
diagnoses and medications was recorded, and the 
following questions were included to diagnose 
asthma: 
Have you had episodes of wheezing in the last 2 yr? 
Have you had episodes of chest tightness in the last 
2 yr? 
Have you had episodes of undue coughing in the 
last 2 yr? 
Have you been abnormally short of breath in the 
last 2 yr? 
Has a doctor ever said that you have asthma? 
Airway responsiveness to methacholine was 
measured in each subject using a standardized 
dosimeter method (5). Doubling cumulative doses 
(3.125-6400 pug) were administered at 5 min intervals 
until there was a greater than 20% fall in FEV, or the 
maximum dose had been administered. The test 
result was expressed as the dose estimated to provoke 
a 20% decrement in FEV, (PD,,FEV,) by linear 
interpolation from the dose-response graph. 
Recognition of bronchoconstriction was assessed 
in the final stages of the airway responsiveness 
measurements by asking all subjects whose FEV, 
had fallen by 20% or more (i.e. those who had 
a measurable PD,,FEV,), the question ‘have you 
ever felt like this before’. The question was not 
asked of the subjects who had experienced less 
PD,,FEVt Category 
Fig. I Percentage of study population with a PD,,FEV, at 
or below each cumulative dose level in the methacholine 
challenge protocol. 
than 20% bronchoconstriction, i.e. those in the 
PD,,FEV, >6400 ,ug category, and was inadvertently 
omitted in 30 subjects. The results were analysed 
using a linear logistic model which related the 
probability of recognizing the sensation of bron- 
choconstriction to questionnaire responses and 
P&o (12). 
Results 
The distribution of airway responsiveness measure- 
ments was similar to that described in previous 
epidemiological investigations (Fig. 1) (5). Five- 
hundred and eleven subjects (45%) had quantifiable 
airway responsiveness, i.e. a PDZoFEV, less than 
6400 pg of methacholine. The airway responsiveness 
measurements were closely related to GP diagnoses 
of asthma and use of inhaled medication as recorded 
on the questionnaire (Table 1). 
Three hundred and seventy-three subjects (33%) 
gave a positive response to one or more of the 
questions about respiratory symptoms. These sub- 
jects were evenly distributed throughout the 12 PD,, 
categories, i.e. they bore no obvious relationship to 
airway responsiveness (Fig. 2). Each individual 
symptom was similarly evenly distributed throughout 
the PD,,FEV, categories. 
Four hundred and eighty-one subjects were asked 
‘have you ever felt like this before’ at the end of their 
methacholine challenge tests. Two hundred and 
nineteen answered ‘yes’, 216 answered ‘no’, and 46 
did not know. The proportion of those answering 
‘yes’ was closely related to the airway responsiveness 
measurements, falling from 100% in the lowest PD,, 
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Table I GP diagnoses and use of medication 
PDm 
c/e) 
n (%) with n (“A) using 
diagnosis of inhaled 
n asthma medication 
C6.25 
6.3-12.5 
12625 
25.1L50 
50.1-100 
100~1-200 
200~1400 
400~1-800 
800.1-1600 
1600.1-3200 
3200.16400 
5 
5 
6 
11 
36 
23 
79 
88 
94 
87 
82 
608 
5 (100) 5 (100) 
5 (100) 3 (60) 
5 (83) 4 (80) 
8 (73) 4 (36) 
21 (58) 15 (42) 
10 (43) 7 (32) 
15 (19) 6 (8) 
14 (16) 10 (12) 
11 (12) 3 (3) 
5 (6) 1 (1) 
7 (9) 1 (1) 
13 (2) 6 (1) 
.d” 
5 5 6 11 30 27 74 88 94 87 82 618 
.  .  I I  
PDssFEV, Category 
Fig. 2 Relationship between current respiratory symptoms 
recorded by questionnaire and PD,,FEV, category. The 
total number of subjects represented by each column is also 
shown. 
categories to 27% in the highest (P<O.OOl: Fig. 3). 
The recognition of bronchoconstriction was not 
related to the presence of symptoms recorded on the 
questionnaire before the administration of methacho- 
line (BO.5). It fell with increasing PD,,FEV, in 
parallel among both those who recorded symptoms 
on the questionnaire and those who did not (Table 2). 
This study has demonstrated little relationship 
between responses to a respiratory questionnaire 
used in an epidemiological study of asthma, and 
subjects’ perception of their previous experience of 
bronchoconstriction. At the lowest levels of airway 
responsiveness (PD,,> 1000 pg), two-thirds of the 
- f-l" 
5 10 34 23 71 85 84 84 75 
100 
PD,,FEVr Category 
Fig. 3 The relationship between recognition of broncho- 
constriction and PD,,FEV, category. The numbers are 
slightly different from those of Fig. 2 as the relevant 
question was inadvertently omitted in a number of subjects. 
subjects who reported symptoms of ‘wheeze’, ‘chest 
tightness’, ‘breathlessness’ or ‘abnormal coughing’ on 
the questionnaire claimed not to recognize the sensa- 
tions associated with a 2&30% fall in FEV, when 
this was provoked a short time later. This suggests 
that these subjects were using terms such as ‘wheeze’ 
and ‘chest tightness’ to describe sensations other than 
those associated with bronchoconstriction. On the 
other hand, at higher levels of airway responsiveness 
there were several subjects who recorded no respira- 
tory symptoms on the questionnaire, yet when they 
experienced bronchoconstriction they claimed that 
they had previously experienced the sensation. Thus 
the responses to the respiratory questionnaire in this 
population appeared to be a poor guide to actual 
experience of asthmatic bronchoconstriction. 
The probability of a subject recognizing broncho- 
constriction was much more closely associated with 
airway responsiveness measurements suggesting that 
the latter might be a more reliable method for 
detecting asthma in epidemiological studies - at least 
in working populations. Approximately 8% of the 
study population had a PD,, of 200 pg or less, which 
is equivalent to a PC,, of less than 2 mg ml - ’ using 
the Wright tidal breathing method, and in clinical 
practice is usually associated with active asthma (13). 
Eighty percent of these subjects recognized the 
sensation of bronchoconstriction. At intermediate 
levels of airway responsiveness (PD,, 1000-6400 pg), 
a sizeable proportion of the population (32%) also 
recognized the sensation. It seems unlikely that these 
subjects commonly bronchoconstrict to the point 
of reducing their FEV, by 20-30%, though they 
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Table 2 Questionnaire symptoms and recognition of bronchoconstriction 
Symptoms on questionnaire No symptoms on questionnaire 
% recognizing % recognizing 
PD,, n bronchoconstriction n bronchoconstriction 
C6.25 2 2 (100) 3 3 (100) 
6.3-12.5 1 1 (100) 4 3 (75) 
12.625 1 1 (100) 4 4 (100) 
25.1-50 3 2 (67) 7 7 (100) 
50.1-100 7 6 (86) 21 21 (78) 
100~1-200 6 3 (50) 17 13 (76) 
200~1~00 24 11 (46) 47 18 (38) 
400.1-800 22 13 (59) 63 32 (51) 
800~1-1600 22 8 (38) 62 24 (39) 
1600.1-3200 29 8 (28) 55 19 (35) 
3200.1-6400 22 8 (36) 53 12 (23) 
All 139 63 (45) 342 156 (46) 
probably experience lesser degrees of bronchocon- 
striction from time to time. We did not ask them to 
describe or quantify their sensations following the 
inhalation of methacholine in this study, nor were we 
able to assess the recognition of bronchoconstriction 
among the majority of the population who did not 
have a suthcient degree of bronchoconstriction at the 
end of the methacholine challenge test. 
Histamine-provoked falls in FEV, of 10% or more 
can be perceived by the majority of normal subjects 
as increased breathlessness (15). The bronchocon- 
striction provoked by our tests was considerably 
greater than the threshold for perception but it was 
uniform, in the region of 20-30% below baseline at 
all levels of airway responsiveness. It is likely that the 
subjects’ responses to the question about prior 
experience of symptoms related to this broncho- 
constriction, rather than to vasodilator or other 
properties of the methacholine, as the likelihood of a 
positive response to the question decreased rather 
than increased with PD,, and the total dose of 
methacholine administered. 
The bronchoconstriction provoked by the metha- 
choline acted as a physical ‘illustration’ of asthma. 
Video recordings have also been used in association 
with respiratory questionnaires to illustrate features 
of asthma and have been shown to produce better 
repeatability than written questionnaires alone (14). 
These methods of physically illustrating asthma 
might offer advantages in epidemiological surveys, 
but whether they can ever reliably identify the 
physiological abnormalities of asthma is less clear. 
The subjects who took part in this investigation 
were predominantly healthy young men and the 
study took place in an occupational setting. It is 
possible that the findings were influenced by these, or 
by some feature of the modified MRC respiratory 
questionnaire which we used. The latter is sensitive in 
detecting respiratory symptoms but is not specific for 
asthma. However, given the age range of our subjects 
and their low cumulative smoking histories, the 
results are unlikely to have been confounded by the 
presence of other respiratory diseases such as 
smoking-related chronic obstructive airways disease. 
The overall prevalence of respiratory symptoms 
was not much different to that in a number of other 
epidemiological studies (611). It is possible that 
fitness-consciousness or fears about job security 
played a role in suppressing positive responses to the 
questionnaire in some subjects, while concerns about 
occupational exposures facilitated the reporting of 
symptoms in others. Such biases may have been 
responsible for the poor association between respira- 
tory symptoms and airway responsiveness measure- 
ments in this study. We have demonstrated a closer 
relationship between symptoms and airway respon- 
siveness using similar techniques in a general popu- 
lation study, which suggests that biases were indeed 
distorting the responses to the questionnaire in the 
working population (16). Even in the general popu- 
lation, however, airway responsiveness proved to be 
a better identifier of asthma than questionnaire 
symptoms. 
A poor association between airway responsiveness 
measurements and respiratory symptoms has been a 
common finding in epidemiological studies (6-l 1). 
Biases similar to those which appear to affect work- 
ing populations could operate elsewhere, if for 
example there is local concern about environmental 
pollution or housing conditions. Other commen- 
tators have concluded that the poor association 
between respiratory symptoms and airway respon- 
siveness measurements calls for greater emphasis to 
be placed on the design of questionnaires (8). Our 
results suggest that measurements of airway respon- 
siveness are the more reliable method of diagnosing 
asthma in epidemiological settings, and that any 
change in investigatory emphasis should be in this 
direction. 
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